Lung volume recruitment in patients with Duchenne Muscular Dystrophy in the early non-ambulatory stage

被引:0
作者
Alvarez, Wendy [1 ]
Montero, Sebastian [1 ]
Huerta, Antonio [2 ,3 ]
Moraga, Arlette [1 ]
Saavedra, Cristian [1 ]
Solis, Fresia [1 ]
Prado, Francisco [2 ,3 ,4 ]
机构
[1] Inst Teleton Santiago, Santiago, Chile
[2] Hosp Clin San Borja Arriaran, Serv Pediat, Unidad Hospitalizac Domiciliaria NANEAS, Santiago, Chile
[3] Grp Iberoamer Cuidados Resp Enfermedades Neuromusc, Santiago, Chile
[4] Univ Chile, Dept Pediat & Cirugia, Campus Ctr, Santiago, Chile
来源
ANDES PEDIATRICA | 2025年 / 96卷 / 01期
关键词
Duchenne Muscular Dystrophy; Neuromuscular Disease; Vital Capacity; Cough; Respiratory Muscles; Rehabilitation Center; QUALITY-OF-LIFE; VITAL CAPACITY; INSUFFLATION CAPACITY; RESPIRATORY-FUNCTION; AIR STACKING; VENTILATION; DISORDERS; DIAGNOSIS; HEALTHY;
D O I
10.32641/andespediatr.v96i1.5190
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Ventilatory and cough insufficiency are the main causes of morbidity and mortality in patients with Duchenne muscular dystrophy (DMD). Lung volume recruitment (LVR) might decrease the decline in vital capacity (VC). Objective: To determine the changes produced by respiratory training performed at home with LVR techniques and manually assisted cough on VC, maximum insufflation capacity (MIC), and peak cough flow (PCF) in adolescents with DMD in the early non-ambulatory stage. Patients and Method: Quasi-experimental study with repeated measurements every three months. 16 adolescents with DMD close to the CV plateau and cough insufficiency were evaluated and trained daily in LVR and assisted cough, with follow-up for 12 months, assessing respiratory function, quality of life, and caregiver overload. Results: Eleven users (69%), aged 12.7 +/- 2.8 years, completed the follow-up. Supine position VC and PCF + compression increased significantly (p = 0.047; p = 0.012, respectively). Seated VC and MIC tended to improve by 11.2% and 21.6%, respectively. Quality of life and caregiver overload did not present significant changes. Conclusion: In adolescents with DMD in the early non-ambulatory stage, significant improvements were observed in VC and cough capacity. This provides an intervention of easy implementation, capable of preventing the expected respiratory functional decline.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 50 条
  • [41] Pain characteristics among individuals with Duchenne muscular dystrophy according to their clinical stage
    Kim, Aram
    Park, Mina
    Shin, Hyung-Ik
    BMC MUSCULOSKELETAL DISORDERS, 2022, 23 (01)
  • [42] Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
    Darlene L Machado
    Elaine C Silva
    Maria B D Resende
    Celso R F Carvalho
    Edmar Zanoteli
    Umbertina C Reed
    BMC Research Notes, 5 (1)
  • [43] Continuous monitoring and quantification of multiple parameters of daily physical activity in ambulatory Duchenne muscular dystrophy patients
    Jeannet, Pierre-Yves
    Aminian, Kamiar
    Bloetzer, Clemens
    Najafi, Bijan
    Paraschiv-Ionescu, Anisoara
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2011, 15 (01) : 40 - 47
  • [44] Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength (vol 6, 316, 2018)
    Ebrahimi-Fakhari, Daniel
    Dillmann, Ulrich
    Flotats-Bastardas, Marina
    Poryo, Martin
    Abdul-Khaliq, Hashim
    Shamdeen, Mohammed Ghiath
    Mischo, Bernhard
    Zemlin, Michael
    Meyer, Sascha
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [45] Early developmental milestones in Duchenne muscular dystrophy
    van Dommelen, Paula
    van Dijk, Oisin
    de Wilde, Jeroen A.
    Verkerk, Paul H.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (10) : 1198 - 1204
  • [46] Early neurodevelopmental assessment in Duchenne muscular dystrophy
    Pane, Marika
    Scalise, Roberta
    Berardinelli, Angela
    D'Angelo, Grazia
    Ricotti, Valeria
    Alfieri, Paolo
    Moroni, Isabella
    Hartley, Louise
    Pera, Maria Carmela
    Baranello, Giovanni
    Catteruccia, Michela
    Casalino, Tiziana
    Romeo, Domenico M.
    Graziano, Alessandra
    Gandioli, Claudia
    Bianco, Flaviana
    Mazzone, Elena Stacy
    Lombardo, Maria Elena
    Scoto, Mariacristina
    Sivo, Serena
    Palermo, Concetta
    Gualandi, Francesca
    Sormani, Maria Pia
    Ferlini, Alessandra
    Bertini, Enrico
    Muntoni, Francesco
    Mercuri, Eugenio
    NEUROMUSCULAR DISORDERS, 2013, 23 (06) : 451 - 455
  • [47] Early prednisone treatment in Duchenne muscular dystrophy
    Merlini, L
    Cicognani, A
    Malaspina, E
    Gennari, M
    Gnudi, S
    Talim, B
    Franzoni, E
    MUSCLE & NERVE, 2003, 27 (02) : 222 - 227
  • [48] A review of quality of life themes in Duchenne muscular dystrophy for patients and carers
    Uttley, Lesley
    Carlton, Jill
    Woods, Helen Buckley
    Brazier, John
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
  • [49] Decreased cerebral perfusion in Duchenne muscular dystrophy patients
    Doorenweerd, Nathalie
    Dumas, Eve M.
    Ghariq, Eidrees
    Schmid, Sophie
    Straathof, Chiara S. M.
    Roest, Arno A. W.
    Wokke, Beatrijs H.
    van Zwet, Erik W.
    Webb, Andrew G.
    Hendriksen, Jos G. M.
    van Buchem, Mark A.
    Verschuuren, Jan J. G. M.
    Asllani, Iris
    Niks, Erik H.
    van Osch, Matthias J. P.
    Kan, Helinien E.
    NEUROMUSCULAR DISORDERS, 2017, 27 (01) : 29 - 37
  • [50] Origins and early descriptions of "Duchenne muscular dystrophy"
    Tyler, KL
    MUSCLE & NERVE, 2003, 28 (04) : 402 - 422